September 29, 2021

Regeneron Pharmaceuticals Inc. v. Novartis Pharma AG et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. February 01, 2022

    Novartis Ducks Regeneron's Antitrust Countersuit To IP Fight

    A New York federal judge Monday tossed Regeneron Pharmaceuticals' antitrust lawsuit brought against rival Novartis Pharmaceuticals in response to Novartis' lawsuit claiming Regeneron infringed its patent related to a prefilled syringe treatment.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!